GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Health Sciences Acquisitions Corp 2 (NAS:HSAQ) » Definitions » 14-Day RSI

Health Sciences Acquisitions 2 (Health Sciences Acquisitions 2) 14-Day RSI : N/A (As of Apr. 26, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Health Sciences Acquisitions 2 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-04-26), Health Sciences Acquisitions 2's 14-Day RSI is N/A.

The industry rank for Health Sciences Acquisitions 2's 14-Day RSI or its related term are showing as below:

HSAQ's 14-Day RSI is not ranked *
in the Diversified Financial Services industry.
Industry Median: 52.44
* Ranked among companies with meaningful 14-Day RSI only.

Competitive Comparison of Health Sciences Acquisitions 2's 14-Day RSI

For the Shell Companies subindustry, Health Sciences Acquisitions 2's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Health Sciences Acquisitions 2's 14-Day RSI Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Health Sciences Acquisitions 2's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Health Sciences Acquisitions 2's 14-Day RSI falls into.


Health Sciences Acquisitions 2  (NAS:HSAQ) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100–[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Sciences Acquisitions 2  (NAS:HSAQ) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.

Health Sciences Acquisitions 2 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Health Sciences Acquisitions 2's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.

Health Sciences Acquisitions 2 (Health Sciences Acquisitions 2) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Health Sciences Acquisitions Corp 2 (NAS:HSAQ) » Definitions » 14-Day RSI
Comparable Companies
SAMA AACI BSAQ RCAC LCAP GFOR CLBR NGC HLXA TCOA GSHN PSTH XAMS:EPIC ASZ CCYC CVII KAHC DWAC IPOF PBAJ
Traded in Other Exchanges
N/A
Address
40, 10th Avenue, Floor 7, New York, NY, USA, 10014
Website
Health Sciences Acquisitions Corp 2 is a blank check company.
Executives
Joshua Aiello officer: See Remarks 150 UNION SQUARE DRIVE, NEW HOPE PA 18938
Eric S Fain director ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN MN
Yuval Mika officer: See Remarks 150 UNION SQUARE DRIVE, NEW HOPE PA 18938
Jason Aryeh director 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
David P Hochman director, officer: See Remarks 15 WESTON HILL RD., RIVERSIDE CT 06878
Geoffrey Wade Smith director 6740 SHADY OAK ROAD, EDEN PRAIRIE MN 55344
Pamela Ann Connealy director 320 W 37TH STREET, 3RD FLOOR, NEW YORK NY 10016
Rose Eric A Md director 161 FORT WASHINGTON AVENUE, 7TH FLOOR, NEW YORK NY 10032
Plc Medtronic 10 percent owner 20 ON HATCH, LOWER HATCH STREET, DUBLIN L2 2
Michael Kaswan officer: Chief Financial Officer KBL HEALTHCARE ACQUISITION CORP II, 645 MADISON AVENUE, NEW YORK NY 10022
Darren Sherman director, officer: See Remarks C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Roderick Wong director, 10 percent owner, officer: Chief Executive Officer C/O RTW INVESTMENTS, LP, 40 10TH AVENUE, 7TH FLOOR, NEW YORK NY 10014
Rtw Investments, Lp 10 percent owner 40 10TH AVENUE, 7TH FLOOR, NEW YORK NY 10014
Hsac 2 Holdings, Llc 10 percent owner 412 WEST 15TH STREET, FLOOR 9, NEW YORK NY 10011
Stephanie A Sirota officer: VP-Corp Strategy & Corp Comms. 412 WEST 15TH STREET, FLOOR 9, NEW YORK NY 10011